| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/23/2003 | EP1328289A2 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
| 07/23/2003 | EP1328285A1 Oral preparation containing seaweed for reduction of plaque and calculus |
| 07/23/2003 | EP1328282A1 Efficient method for producing compositions enriched in anthocyanins |
| 07/23/2003 | EP1328272A1 Nf-kappa-b inhibitors |
| 07/23/2003 | EP1328271A2 Method for the treatment of neurological and neuropsychological disorders |
| 07/23/2003 | EP1328270A2 Method for the treatment of neurological and neuropsychological disorders |
| 07/23/2003 | EP1328268A1 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 07/23/2003 | EP1328267A2 Method of treating cancer using dithiocarbamate derivatives |
| 07/23/2003 | EP1328266A1 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 07/23/2003 | EP1328261A2 Treatment of neurodegenerative disease |
| 07/23/2003 | EP1328260A2 Methods and products related to pulmonary delivery of polysaccharides |
| 07/23/2003 | EP1328254A2 Lipid formulations for target delivery |
| 07/23/2003 | EP1254260A4 Methods for diagnosing and treating heart disease |
| 07/23/2003 | EP1254134B1 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors |
| 07/23/2003 | EP1228073B1 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 07/23/2003 | EP1154785B1 Inhibitors for use in hemostasis and immune function |
| 07/23/2003 | EP1140199B1 Hyaluronate lyase used for promoting penetration in topical agents |
| 07/23/2003 | EP1128784B1 Therapeutic use of polymers |
| 07/23/2003 | EP1107741B1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 07/23/2003 | EP1086096B1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 07/23/2003 | EP1079829B1 Use of benzofuroxan derivatives in treating angina pectoris |
| 07/23/2003 | EP1075259B1 Novel fatty analogues for the treatment of diabetes |
| 07/23/2003 | EP1073445B1 Substance mixture for topical application comprising olive oil and honey |
| 07/23/2003 | EP1032575B1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 07/23/2003 | EP0898559B1 Cytoprotective compounds |
| 07/23/2003 | EP0888278B1 Antidiabetic agents |
| 07/23/2003 | EP0871665B1 Insulin derivatives |
| 07/23/2003 | EP0814827B1 Vascular endothelial growth factor-b |
| 07/23/2003 | EP0695183B1 Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders |
| 07/23/2003 | CN1432020A 嘌呤衍生物 Purine derivatives |
| 07/23/2003 | CN1432018A Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound |
| 07/23/2003 | CN1432015A Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 07/23/2003 | CN1432012A Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 07/23/2003 | CN1432011A Benzoamide piperidine compounds as substance P antagonists |
| 07/23/2003 | CN1432007A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/23/2003 | CN1431999A Indole derivatives with vascular damagine activity |
| 07/23/2003 | CN1431941A 挤压模 Extrusion die |
| 07/23/2003 | CN1431915A Treatment of congestive heart failure with compsn. comprising diuretic agent and vasopressin antagonist |
| 07/23/2003 | CN1431908A Kits and methods for optimizing efficacy of chondroprotective compsns. |
| 07/23/2003 | CN1431904A Protease inhitors |
| 07/23/2003 | CN1431902A Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 07/23/2003 | CN1431900A Methods and compsns. useful in enhancing oxygon delivery to cells |
| 07/23/2003 | CN1431898A Methods of use of penicillamines for treatment of conditions resulting from DNA damage |
| 07/23/2003 | CN1431204A Method for preparing water-soluble soybean aglycon and its applications |
| 07/23/2003 | CN1430997A Compound Chinese medical preparation for curing cardiovascular, cerebrovascular diseases and its preparing method |
| 07/23/2003 | CN1430994A Chinese medical prepn. for preventing and curing cardiovascular, cerebrovascular diseases and its prodn. method |
| 07/23/2003 | CN1430992A ÔÇÿXiangdanÔÇÖ drop liquid for treating angiocardiopathy |
| 07/23/2003 | CN1430990A Detoxification tea of white bamboo |
| 07/23/2003 | CN1430983A Liquid preparation of gingko leaves and its preparing method |
| 07/23/2003 | CN1430974A Musk capsule for anti-thrombus |
| 07/23/2003 | CN1430968A Injection liquid of extractive gingko leaves and its preparing method |
| 07/23/2003 | CN1430966A Medicine combination contg. effective part of astragalus root |
| 07/23/2003 | CN1430965A Soft capsule of puerarin and preparing method thereof |
| 07/23/2003 | CN1430963A Slowly releasing tablet of ligustrazine of phosphoric acid and its preparing method |
| 07/23/2003 | CN1430954A Soft capsule in total flavone of hawthorn leaves and its preparing method |
| 07/23/2003 | CN1115339C Novel sulfonylaminopyrimidines |
| 07/23/2003 | CN1115159C Red sage contg. medicine compsn. and its prepn. process and application |
| 07/23/2003 | CN1115156C Antisenescence Chinese medicine |
| 07/23/2003 | CN1115154C Piles medicine |
| 07/23/2003 | CN1115151C Mixture of vasodilating agents and medical diluet or carrier in prepn. of medicine for treating liver disease |
| 07/22/2003 | US6596900 Brain, nervous system, neurodegenerative, gastrointestinal, sleep, rheumatic, and psychological disorders; analgesics, antiepileptic agents |
| 07/22/2003 | US6596874 Salt formation by reaction using benzenesulfonic acid |
| 07/22/2003 | US6596867 Bone disorders |
| 07/22/2003 | US6596769 20-Hete antagonists and agonists |
| 07/22/2003 | US6596766 Method for relieving arachidonic acid deficient conditions and maintaining a good fatty acid balance in vivo in mammals excluding humans, comprising the process of administering 4, 7, 10, 13, 16-docosapentaenoic acid (DPA)-containing material |
| 07/22/2003 | US6596764 Method of preparing diacetyl rhein |
| 07/22/2003 | US6596758 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
| 07/22/2003 | US6596751 α-substituted carboxylic acid derivatives |
| 07/22/2003 | US6596749 Neuropeptide y receptor ligand |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |
| 07/22/2003 | US6596745 Method for treating fibrotic diseases with azolium chroman compounds |
| 07/22/2003 | US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): |
| 07/22/2003 | US6596733 Nitric oxide scavengers, such as dithiocarbamate-containing compounds, are used to reduce side effects caused by therapeutical administration of nitric oxide sources |
| 07/22/2003 | US6596732 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 07/22/2003 | US6596731 Substituted imidazo[1,2-A] pyridine derivatives |
| 07/22/2003 | US6596730 Phenyl urea and phenyl thiourea derivatives |
| 07/22/2003 | US6596728 A pharmaceutical composition, comprising at least one compound or salt thereof as claimed in claim 1 and a polypeptides with excipients |
| 07/22/2003 | US6596719 6 alkoxy-4-pyrimidinyl bis-sulfonamides |
| 07/22/2003 | US6596718 7-Morpholin-4yl-benzothiazole amide derivatives |
| 07/22/2003 | US6596711 GABA B receptor agonists for use in the treatment of CNS disorders, such as muscle relaxation in spinal spasticity, cardiovascular disorders, asthma, gut motility disorders such as irritable bowel syndrome and gastroesophogeal reflux |
| 07/22/2003 | US6596709 6-sulphanoyl-3-quinolylphosphonic acid compounds |
| 07/22/2003 | US6596706 For the treatment of circulatory diseases cerebral diseases |
| 07/22/2003 | US6596701 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/22/2003 | US6596698 Localized arterial transduction of RB2/pl30 via a viral vector at the time of angioplasty drastically reduces neointimal hyperplasia and prevents restenosis |
| 07/22/2003 | US6596491 Tenascin-C nucleic acid ligands |
| 07/22/2003 | US6596321 Pharmaceutical composition for treating angiocardiopathy and the method of producing thereof |
| 07/22/2003 | US6595926 Method for evaluating and treating hypertension |
| 07/22/2003 | CA2294422C Tartrate salt of a substituted dipeptide |
| 07/22/2003 | CA2198833C Carnitine derivative-containing medicament for treating chronic arteriosclerosis obliterans |
| 07/21/2003 | CA2416791A1 A receptor-ligand pairing for immune response |
| 07/21/2003 | CA2368656A1 Receptor-ligand pairing for anti-inflammatory response |
| 07/17/2003 | WO2003058203A2 Extended glucagon-like peptide-1 analogs |
| 07/17/2003 | WO2003057911A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |
| 07/17/2003 | WO2003057888A1 Cell-specific expression/replication vector |
| 07/17/2003 | WO2003057867A2 Regulation of human fatty acid coa ligase-like amp-binding enzyme |
| 07/17/2003 | WO2003057856A2 Dominant negative proteins and methods thereof |
| 07/17/2003 | WO2003057829A2 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 07/17/2003 | WO2003057707A1 2-o-( -d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 07/17/2003 | WO2003057699A1 Dibenzodiazepine derivates, their preparation and use |